Short Summary
The PTAB held that most of the claims of Netlist’s ’907 memory‑module patent were obvious over the Ellsberry reference (alone or combined with standards), cancelling 63 of 65 claims. Claims 40 and 41 survived.
Detailed Summary
In IPR2018‑00362, the Patent Trial and Appeal Board examined Netlist’s U.S. Patent No. 9,606,907 B2 covering a memory module architecture. Samsung Electronics (as petitioner) asserted that the claims were obvious over the prior‑art device disclosed in Ellsberry, either alone or in combination with industry standards such as JEDEC JESD21‑C, Halbert, Ruckerbauer, and Stone. Netlist argued that the petitioner improperly mixed mutually exclusive embodiments of Ellsberry. After extensive claim‑by‑claim analysis, the Board concluded that a person of ordinary skill would have been motivated to combine the teachings and found claims 1‑39 and 42‑65 unpatentable as obvious under 35 U.S.C. § 103(a). Claims 40 and 41 were not found unpatentable. The decision finalizes the institution of the trial and the cancellation of the majority of the patent’s claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Samsung Electronics Co., Ltd. et al. vs Netlist, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
REVELYST SALES LLC et al.vsBrainGuard Technologies Inc.
Revelyst Sales LLC petitions the PTAB to invalidate 16 claims of BrainGuard Technologies’ helmet patent, alleging obviousness and anticipation over multiple prior‑art helmets that employ sliding layers and chin‑strap configurations.
Curio Bioscience et al.vsPrognosys Biosciences Inc. et al.
Curio Bioscience has filed an IPR petition seeking cancellation of 17 claims of the ‘022 patent covering spatially encoded biological assays, arguing obviousness over Cantor and Armani and anticipation by Frisen.
Inari Agriculture, Inc.vsPioneer Hi-Bred International, Inc.
The USPTO Director denied Inari Agriculture's request for a Director Review of the PTAB's institution denial, leaving Pioneer Hi‑Bred's seed patent intact.
Jeisys Medical Inc. et al.vsSerendia, LLC
Serendia requests Director Review to terminate IPR2024-00384, arguing the Board improperly expedited institution of time‑barred petitions despite a pending ITC validity finding. The petition cites the rescinded Fintiv memo and extraordinary circumstances to seek dismissal.
AMAZON.COM, INC. et al.vsNokia Technologies Oy
Amazon and Nokia have settled their IPR over U.S. Patent 7,532,808 and filed a joint request to treat the settlement documents as confidential. The parties seek termination of the proceeding while keeping the settlement details out of the public record.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.